As of August 28, 2026, Inhibikase Therapeutics, Inc. (IKT) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. Inhibikase Therapeutics, Inc. has a market capitalization of $231.06M, 139.54M shares outstanding, 104 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split
model est. 30%
• 50-day avg $1.79 approaching $1 threshold
Market Data
Market Cap$231.06M
Shares Outstanding139.54M
Float86.88M
Cash$306.61M
Debt$381.8K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 9.6% shares (2026Q1 vs prior)
104 institutional holders · 125.60M shares
#1
Sands Capital Alternatives, LLC
13.02M shares
#2
Soleus Capital Management, L.P.
10.88M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
8.90M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest19.14M
Days to Cover21.5
% of Float22.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2020-12-28
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual IKT Dilution Snapshot
Inhibikase Therapeutics, Inc. (IKT) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for IKT: xbrl on 2020-12-28.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track IKT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IKT — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for IKT
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.